Discover the Latest in Dry AMD Treatment with John Rose Optometrist
Join optometrist John Rose in conversation with journalist Angela Young as they discuss the FDA-approved Valeda Light Delivery System (LDS) treatment for Dry Age-Related Macular Degeneration (AMD). Hear directly from John and Alita, one of our AMD patients, about how this innovative therapy works and their personal experience with Valeda.
On this pocast you can follow the journey of Angela Young as an AMD patient. Angela hosts the podcast series “TALKIN’ ‘Bout Degeneration” and she candidly explores her personal journey with age-related macular degeneration (AMD), shedding light on living with this condition.
Angela’s story took a hopeful turn with the LumiThera Valeda Light Delivery System (LDS) treatment. As a pioneer in photobiomodulation therapy for AMD, the Valeda LDS offers a non-invasive solution that has made a tangible difference in Angela’s vision and quality of life.
Her podcast is a must-listen for anyone affected by AMD or curious about cutting-edge treatments. 🎧✨
We’re proud to share that the LumiThera Valeda Light Delivery System (LDS) has recently achieved FDA approval, solidifying its position as a groundbreaking treatment for dry age-related macular degeneration (AMD).
This cutting-edge photobiomodulation therapy was recently showcased at the Scottish Optical Conference (SOC) in Glasgow, where we introduced the Valeda device to Scottish optometrists. The response was incredible, highlighting the device’s potential to transform AMD care in high street practices.
With its ability to deliver non-invasive, evidence-based treatment, Valeda empowers optometrists to play a pivotal role in the early management and ongoing care of AMD patients. This innovation bridges the gap between primary and specialist care, offering hope and improved outcomes for countless patients.
We’re excited to lead this paradigm shift in vision care—bringing advanced solutions directly to our communities.
#AMD #LumiTheraValeda #Photobiomodulation #EyeCareInnovation #ScottishOptometry #SOC2024 #FutureOfVisionCare
#AMD #PodcastSpotlight #LumiThera #ValedaLDS #JohnRoseEyeCare #VisionHealth